Redox Regulation of Immunometabolism in Microglia Underpinning Diabetic Retinopathy
Antioxidants · 29.03.2024 · 13 (4) · 423
DOI: 10.3390/antiox13040423 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 29.03.2024. Verfasst von Luwei Cai und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Eye Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, Chi…. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Pujiang Program, Key R&D project of the National Ministry of Science and Technology.
Abstract (Originalsprache)
Diabetic retinopathy (DR) is the leading cause of visual impairment and blindness among the working-age population. Microglia, resident immune cells in the retina, are recognized as crucial drivers in the DR process. Microglia activation is a tightly regulated immunometabolic process. In the early stages of DR, the M1 phenotype commonly shifts from oxidative phosphorylation to aerobic glycolysis for energy production. Emerging evidence suggests that microglia in DR not only engage specific metabolic pathways but also rearrange their oxidation-reduction (redox) system. This redox adaptation supports metabolic reprogramming and offers potential therapeutic strategies using antioxidants. Here, we provide an overview of recent insights into the involvement of reactive oxygen species and the distinct roles played by key cellular antioxidant pathways, including the NADPH oxidase 2 system, which promotes glycolysis via enhanced glucose transporter 4 translocation to the cell membrane through the AKT/mTOR pathway, as well as the involvement of the thioredoxin and nuclear factor E2-related factor 2 antioxidant systems, which maintain microglia in an anti-inflammatory state. Therefore, we highlight the potential for targeting the modulation of microglial redox metabolism to offer new concepts for DR treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Clinical Research Center for Eye Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.
- Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai 200080, China.
- Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai 200080, China.
- Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai 200080, China.
ORCID-Profile: Mengxue Xia
Förderung
- National Natural Science Foundation of China
- Shanghai Pujiang Program
- Key R&D project of the National Ministry of Science and Technology
Zitieren
APA
Cai, L., Xia, M., & Zhang, F. (2024). Redox Regulation of Immunometabolism in Microglia Underpinning Diabetic Retinopathy. Antioxidants, 13(4), 423. https://doi.org/10.3390/antiox13040423
Vancouver
Cai L, Xia M, Zhang F. Redox Regulation of Immunometabolism in Microglia Underpinning Diabetic Retinopathy. Antioxidants. 2024;13(4):423. doi:10.3390/antiox13040423
BibTeX
@article{Cai2024,
author = {Cai, Luwei and Xia, Mengxue and Zhang, Fang},
title = {Redox Regulation of Immunometabolism in Microglia Underpinning Diabetic Retinopathy},
journal = {Antioxidants},
year = {2024},
volume = {13},
number = {4},
pages = {423},
doi = {10.3390/antiox13040423}
}
EUVIMED